Increased metabolism has been identified as a significant mechanism of weight loss when taking GTP-1 agonists
Irish researchers conducted a randomized controlled trial and found that the effects of glucagon-like peptide-1 (GPP-1) receptor agonists were not only due to a reduction in appetite and calorie intake, as commonly believed, but also to an increase in visceral adipose tissue metabolism
29.08.2024